Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategy
Kidney International · 2025-06 · 107 (6) · 1099-1103
DOI: 10.1016/j.kint.2025.01.019 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Kidney International, 2025-06. Verfasst von Felicitas E Hengel und 13 weiteren Autor:innen. Beteiligte Einrichtung: III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Hamburg Center for Kidney Health (HCKH), University Medic…. Hauptthemen laut MEDLINE: Nephrotic Syndrome, Autoantibodies, Membrane Proteins, Immunosuppressive Agents. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation, European Research Council, European Paediatric Neurology Society.
Abstract (Originalsprache)
INTRODUCTION: Autoantibodies against the podocyte protein nephrin were recently identified in a pediatric cohort primarily comprising steroid-sensitive (SSNS) and steroid-dependent (SDNS) nephrotic syndrome (NS). However, their prevalence across all NS subtypes, particularly in steroid-resistant nephrotic syndrome (SRNS), and their relation to therapy response need to be determined to advance pathophysiological understanding and refine treatment strategies. METHODS: A multicenter cohort study measuring anti-nephrin autoantibodies in samples from children with SSNS, SDNS, nongenetic and genetic SRNS was conducted. RESULTS: Sixty-nine of 101 (68%) patients with SSNS, 19 of 67 (28%) patients with SDNS, 14 of 103 patients (14%) with non-genetic SRNS, and 1 of 62 patients (2%) with genetic SRNS were positive for anti-nephrin autoantibodies. The prevalence of anti-nephrin autoantibodies increased with presence of active disease in cases of SSNS and SDNS. Within the group of non-genetic SRNS patients with active disease, anti-nephrin positivity was found in 13 of 74 (18%) patients responding to intensified immunosuppression compared to none of 17 patients with multidrug-resistant SRNS. CONCLUSIONS: The prevalence of anti-nephrin antibodies is substantially higher in children with steroid responsive NS than in those with SRNS, suggesting that anti-nephrin antibodies primarily drive SSNS/SDNS. In contrast, NS due to podocyte gene mutations is primarily genotype-caused. Anti-nephrin autoantibodies may serve as a positive prognostic marker in pediatric NS, indicating a favorable response to immunosuppressive therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Hamburg Center for Kidney Health (HCKH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Hamburg Center for Tran…
- III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Hamburg Center for Kidney Health (HCKH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Pediatric Nephrology Department, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.
- Department of Pediatric Nephrology, Cukurova University, Adana, Türkiye.
- Department of Pediatric Nephrology, Hacettepe University, Ankara, Türkiye; Department of Bioinformatics, Hacettepe University, Ankara, Türkiye; Nephrogenetics Laboratory, Department of Pediatric Nephrology, Hacettepe Un…
- Department of Pediatric Nephrology, University Children's Hospital, Belgrade, Serbia.
Förderung
- German Research Foundation
- European Research Council
- European Paediatric Neurology Society
- Else Kröner-Fresenius-Stiftung
- European Rare Kidney Disease Reference Network
- Agence Nationale de la Recherche
- Bundesministerium fur Bildung und Forschung Dienststelle Berlin
- Bundesministerium für Bildung und Forschung
Zitieren
APA
Hengel, F. E., Dehde, S., Yilmaz, A., Bayazit, A. K., Ozaltin, F., Paripovic, D., Emma, F., Ronco, P., Vivarelli, M., Hogan, J., Schaefer, F., Tomas, N. M., Huber, T. B., & PodoNet Consortium and the International Society of Glomerular Disease (2025). Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategy. Kidney International, 107(6), 1099-1103. https://doi.org/10.1016/j.kint.2025.01.019
Vancouver
Hengel FE, Dehde S, Yilmaz A, Bayazit AK, Ozaltin F, Paripovic D, et al. Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategy. Kidney International. 2025;107(6):1099-1103. doi:10.1016/j.kint.2025.01.019
BibTeX
@article{Hengel2025,
author = {Hengel, Felicitas E and Dehde, Silke and Yilmaz, Alev and Bayazit, Aysun K and Ozaltin, Fatih and Paripovic, Dusan and Emma, Francesco and Ronco, Pierre and Vivarelli, Marina and Hogan, Julien and Schaefer, Franz and Tomas, Nicola M and Huber, Tobias B and PodoNet Consortium and the International Society of Glomerular Disease, PodoNet Consortium and the International Society of Glomerular Disease},
title = {Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategy},
journal = {Kidney International},
year = {2025},
volume = {107},
number = {6},
pages = {1099--1103},
doi = {10.1016/j.kint.2025.01.019}
}
EUVIMED